BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 25678217)

  • 1. Comparing the effects of ketotifen fumarate eye drops and ketotifen oral pills on symptom severity and quality of life in patients with allergic rhinitis: a double-blind randomized clinical trial.
    Akhavan A; Karimi-Sari H; Khosravi MH; Arefzadeh E; Yavarahmadi M
    Int Forum Allergy Rhinol; 2015 May; 5(5):386-91. PubMed ID: 25678217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.
    Crampton HJ
    Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the relative clinical efficacy of a single dose of ketotifen fumarate 0.025% ophthalmic solution versus placebo in inhibiting the signs and symptoms of allergic rhinoconjunctivitis as induced by the conjunctival allergen challenge model.
    Crampton HJ
    Clin Ther; 2002 Nov; 24(11):1800-8. PubMed ID: 12501875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.
    Lai DS; Lue KH; Hsieh JC; Lin KL; Lee HS
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM; Tekelioglu Y; Turk A; Akyol N
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference.
    Leonardi A; Zafirakis P
    Curr Med Res Opin; 2004 Aug; 20(8):1167-73. PubMed ID: 15324519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model.
    D'Arienzo PA; Leonardi A; Bensch G
    Clin Ther; 2002 Mar; 24(3):409-16. PubMed ID: 11952024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W; Hampel F; Bernstein J; Shah S; Sacks H; Meltzer EO
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ketotifen fumarate 0.025% ophthalmic solution compared with placebo in the conjunctival allergen challenge model.
    Abelson MB; Chapin MJ; Kapik BM; Shams NB
    Arch Ophthalmol; 2003 May; 121(5):626-30. PubMed ID: 12742839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
    Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
    Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ketotifen fumarate (Zaditen) eye drops in the treatment of seasonal allergic conjunctivitis].
    Haicl P; Cerná H
    Cesk Slov Oftalmol; 2004 Sep; 60(5):362-7. PubMed ID: 15566225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of preservative-free ketotifen fumarate and preserved olopatadine hydrochloride eye drops in the treatment of moderate to severe seasonal allergic conjunctivitis.
    Mortemousque B; Bourcier T; Khairallah M; Messaoud R; Brignole-Baudouin F; Renault D; Rebika H; Brémond-Gignac D;
    J Fr Ophtalmol; 2014 Jan; 37(1):1-8. PubMed ID: 24388379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
    Karaki M; Akiyama K; Mori N
    Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment of allergic rhinitis using ketotifen fumarate and budesonide administered as nasal sprays
.
    Wang SZ; Yao Y; Zhang XJ; Duan X; Guo LR; Jia Y; Wang D; Tian YS
    Int J Clin Pharmacol Ther; 2020 Apr; 58(4):195-197. PubMed ID: 32068532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis.
    Kidd M; McKenzie SH; Steven I; Cooper C; Lanz R;
    Br J Ophthalmol; 2003 Oct; 87(10):1206-11. PubMed ID: 14507747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "physician on call patient engagement trial" (POPET): measuring the impact of a mobile patient engagement application on health outcomes and quality of life in allergic rhinitis and asthma patients.
    Cingi C; Yorgancioglu A; Cingi CC; Oguzulgen K; Muluk NB; Ulusoy S; Orhon N; Yumru C; Gokdag D; Karakaya G; Çelebi Ş; Çobanoglu HB; Unlu H; Aksoy MA
    Int Forum Allergy Rhinol; 2015 Jun; 5(6):487-97. PubMed ID: 25856270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and clinical characteristics of patients with non-allergic rhinitis].
    Wang H; Zhang J; You S; Ao Y; Bai Y; Shi H; Ji L; Jia J; Zhang Y; Jia H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jun; 49(6):501-5. PubMed ID: 25241870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
    Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ketotifen fumarate 0.025% in the conjunctival antigen challenge model of ocular allergic conjunctivitis.
    Greiner JV; Mundorf T; Dubiner H; Lonsdale J; Casey R; Parver L; Kapik BM; Shams NB; Abelson MB
    Am J Ophthalmol; 2003 Dec; 136(6):1097-105. PubMed ID: 14644221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of single- and multiple-dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric population.
    Abelson MB; Ferzola NJ; McWhirter CL; Crampton HJ
    Pediatr Allergy Immunol; 2004 Dec; 15(6):551-7. PubMed ID: 15610370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.